Hormel Foods Recalls Planters Nuts for Potential Listeria Contamination 
Peloton CEO Quits, Company Slashes 15% of Its Workforce as Restructuring Begins 
Adidas Strategizes to Sustain Sneaker Sales Surge as Samba, Gazelle Drive Growth 
Nike and Kylian Mbappé Inspire Youth through Sports in Paris 
Leak: Huawei's Kirin PC Chip, Qingyun Notebooks to Launch Next Month 
Paramount Continues Talks With Skydance While Negotiating With Sony and Apollo 
Coca-Cola Europacific Partners’ Finance Chief Resigns, Moves to Johnnie Walker’s Diageo Company 
Indian Coca-Cola Bottler HCCB Eyes IPO Amid Expansion and Growth Opportunities 
Brooks Running Targets Growth in China and Europe 
Sony Pictures, Apollo Looking to Jointly Acquire Paramount, Propose $26 Billion Cash Deal 
Adidas Originals Teams up With Dingyun Zhang to Reinvent the Samba Silhouette 
Monster Beverage Sees Robust Growth with an 11.8% Revenue Surge 
Al Jazeera Media Operations Ordered Shut By Israel; World Denounces Move 
Jack Dorsey, Former Twitter CEO, Leaves Bluesky Board 
Kellanova Beats Expectations with Strong Q1 Sales Amid Higher Prices 
Tesla Drivers Get $4k Off 2024 Chevy Blazer EV; Costco Auto Slashes Prices on New EVs 
Arby’s Unveils New Menu Additions Plus Beyoncé-Inspired Chardonnay-Infused Sauce 
NEW YORK, March 18, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of investors who purchased Nobilis Health Corp. (NYSE:HLTH) securities between April 2, 2015 and January 6, 2016.
Click here to learn about the case: http://docs.wongesq.com/HLTH-Info-Request-Form-951. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Nobilis’ financial statements contained numerous errors concerning the classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results; (2) Nobilis overstated its net income for the year ended December 31, 2014 by more than $4 million; (3) Nobilis overstated its net income for the quarter ended March 31, 2015 by more than $3.27 million; and (4) as a result, defendants’ statements about Nobilis’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
If you suffered a loss in Nobilis Health you have until March 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/HLTH-Info-Request-Form-951.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
